Particle size limits to meet USP content uniformity criteria for tablets and capsules.
about
An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms.Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.Development of an ultra high performance liquid chromatography method for determining triamcinolone acetonide in hydrogels using the design of experiments/design space strategy in combination with process capability index.Fabrication and optimization of camptothecin loaded Eudragit S 100 nanoparticles by Taguchi L4 orthogonal array design.Towards integrated drug substance and drug product design for an active pharmaceutical ingredient using particle engineering.The manufacture of low-dose oral solid dosage form to support early clinical studies using an automated micro-filing system.Solubilization of entecavir by povidone to overcome content uniformity challenges for low-dose tablet formulations.Method to study the effect of blend flowability on the homogeneity of acetaminophen.Influence of formulation composition and processing on the content uniformity of low-dose tablets manufactured at kilogram scale.Evaluation of transmission and reflection modalities for measuring content uniformity of pharmaceutical tablets with near-infrared spectroscopy.
P2860
Q36400459-4D259367-4983-4EF2-BEF9-C9CE33C3D080Q36442112-F2BCFCAA-3030-4F89-88FB-248E1243F487Q38243872-46ED77B9-7305-4003-83ED-10DF911B1EFFQ38353795-A1BC0499-820F-4E11-A37E-2D9813B981A3Q39762701-0E98DFB0-3CBB-429E-AED8-909E5A0757B0Q40642201-A7FA6ABA-D4FB-4532-8895-3A2A3CA58093Q41821350-ACEEA529-64E4-43FD-84D7-AE6F02667F93Q42079040-689659AC-D243-49D0-B531-ECCA2F75F34CQ44073216-5EFA59F3-65C8-4A44-93DF-9A4D65AC0BF9Q44926442-DB229C35-3F4E-436D-B334-A9A14EEDE75FQ45954891-DD18B00A-E9D1-4D72-80CC-5F99AFD2EACBQ51856312-AFF29C62-6195-437D-9523-23BEE9FE631E
P2860
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
@en
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
@nl
type
label
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
@en
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
@nl
prefLabel
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
@en
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
@nl
P2093
P356
P1476
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
@en
P2093
Brian R Rohrs
Connie J Skoug
Gregory E Amidon
Harry M King
Pamela J Secreast
Richard H Meury
P304
P356
10.1002/JPS.20587
P407
P577
2006-05-01T00:00:00Z